Nivolumab With or Without Varlilumab in Treating Patients With Relapsed or Refractory Aggressive B-cell Lymphomas
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
33 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Mayo Clinic Hospital in Arizona
Phoenix, Arizona, United States
- Mayo Clinic in Arizona
Scottsdale, Arizona, United States
- Mayo Clinic in Florida
Jacksonville, Florida, United States
- Moffitt Cancer Center
Tampa, Florida, United States
- Moffitt Cancer Center - Mckinley Campus
Tampa, Florida, United States
- Moffitt Cancer Center-International Plaza
Tampa, Florida, United States
- Northside Hospital
Atlanta, Georgia, United States
- Northwestern University
Chicago, Illinois, United States
- University of Chicago Comprehensive Cancer Center
Chicago, Illinois, United States
- University of Kansas Clinical Research Center
Fairway, Kansas, United States
- Haysmed
Hays, Kansas, United States
- University of Kansas Cancer Center
Kansas City, Kansas, United States
- Lawrence Memorial Hospital
Lawrence, Kansas, United States
- the University of Kansas Cancer Center - Olathe
Olathe, Kansas, United States
- University of Kansas Cancer Center-Overland Park
Overland Park, Kansas, United States
- University of Kansas Hospital-Indian Creek Campus
Overland Park, Kansas, United States
- Mercy Hospital Pittsburg
Pittsburg, Kansas, United States
- Salina Regional Health Center
Salina, Kansas, United States
- University of Kansas Health System Saint Francis Campus
Topeka, Kansas, United States
- University of Kansas Hospital-Westwood Cancer Center
Westwood, Kansas, United States
- Mayo Clinic in Rochester
Rochester, Minnesota, United States
- Siteman Cancer Center at Saint Peters Hospital
City of Saint Peters, Missouri, United States
- Siteman Cancer Center at West County Hospital
Creve Coeur, Missouri, United States
- University Health Truman Medical Center
Kansas City, Missouri, United States
- University of Kansas Cancer Center - North
Kansas City, Missouri, United States
- University of Kansas Cancer Center - Lee'S Summit
Lee's Summit, Missouri, United States
- University of Kansas Cancer Center at North Kansas City Hospital
North Kansas City, Missouri, United States
- Siteman Cancer Center-South County
St Louis, Missouri, United States
- Washington University School of Medicine
St Louis, Missouri, United States
- Dartmouth Hitchcock Medical Center/dartmouth Cancer Center
Lebanon, New Hampshire, United States
- Roswell Park Cancer Institute
Buffalo, New York, United States
- Laura and Isaac Perlmutter Cancer Center at Nyu Langone
New York, New York, United States
- Ut Southwestern/simmons Cancer Center-Dallas
Dallas, Texas, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 21 Dec 2018
- Primary completion
- 26 May 2023
- Completion
- 24 Oct 2026
- Last update posted
- 12 May 2026
- Registered enrollment
- 54
- Registry id
- NCT03038672
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.